☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Retinal diseases
AbbVie Collaborates with Regenxbio to Develop and Commercialize RGX-314 for the Treatment of Retinal Diseases
September 13, 2021
Merck Amends Collaboration with NGM to Advance Novel Therapies for Retinal and CVM Diseases
July 5, 2021
Boehringer Ingelheim Enters into an Agreement with Inflammasome Therapeutics to Co-Develop Therapies for Retinal Diseases
September 20, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
